Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations.
暂无分享,去创建一个
L. J. Lee | K. Ghoshal | S. Jacob | X. Mo | Hongyan He | Xinmei Wang | Robert J. Lee | Chenguang Zhou | Bo Yu | H. Jia | Lu Wang | Wei Ren | H. Jia | L. James Lee | Samson T. Jacob | Robert J. Lee
[1] L. J. Lee,et al. Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[2] X. Jing,et al. Size-dependent biodistribution and antitumor efficacy of polymer micelle drug delivery systems. , 2013, Journal of materials chemistry. B.
[3] D. Rockey,et al. Altered Mental Status in Cirrhosis , 2013, Journal of Investigative Medicine.
[4] Isobel Leake. Liver: Size matters: effects of reduced paracetamol pack sizes in England and Wales , 2013, Nature Reviews Gastroenterology &Hepatology.
[5] N. Svrzikapa,et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. , 2013, Cancer discovery.
[6] K. Ghoshal,et al. Lipid nanoparticles for hepatic delivery of small interfering RNA. , 2012, Biomaterials.
[7] Hsien-Da Huang,et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. , 2012, The Journal of clinical investigation.
[8] M. Caligiuri,et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. , 2012, The Journal of clinical investigation.
[9] Bo Yu,et al. SPANosomes as delivery vehicles for small interfering RNA (siRNA). , 2012, Molecular pharmaceutics.
[10] J. Yano,et al. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA. , 2011, Biological & pharmaceutical bulletin.
[11] Bo Yu,et al. MicroRNA delivery by cationic lipoplexes for lung cancer therapy. , 2011, Molecular pharmaceutics.
[12] B. Polisky,et al. An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA. , 2011, Molecular Therapy.
[13] L. J. Lee,et al. Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery. , 2011, Anticancer research.
[14] S. Fesik,et al. A robust in vivo positive-readout system for monitoring siRNA delivery to xenograft tumors. , 2011, RNA.
[15] Daniel A. Balazs,et al. Liposomes for Use in Gene Delivery , 2010, Journal of drug delivery.
[16] Zhan Yuin Ong,et al. Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases , 2010 .
[17] Andrew D. Miller,et al. DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[18] Mark E. Davis,et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.
[19] K. G. Rajeev,et al. Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.
[20] Kathryn A. Whitehead,et al. Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.
[21] R. Langer,et al. Lipid‐based nanotherapeutics for siRNA delivery , 2010, Journal of internal medicine.
[22] K. Ghoshal,et al. TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.
[23] A. Judge,et al. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. , 2009, The Journal of clinical investigation.
[24] X. Wang,et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.
[25] Jen-Leih Wu,et al. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. , 2008, Biochemical and biophysical research communications.
[26] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[27] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[28] F. Dosio,et al. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.
[29] J. Heyes,et al. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[30] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[31] V. Vlassov,et al. Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. , 2002, Bioelectrochemistry.
[32] Ana Ivelisse Avilés,et al. Linear Mixed Models for Longitudinal Data , 2001, Technometrics.
[33] Y. Maitani,et al. MODIFIED ETHANOL INJECTION METHOD FOR LIPOSOMES CONTAINING β-SITOSTEROL β-D-GLUCOSIDE , 2001, Journal of liposome research.
[34] Guisheng Zhang,et al. Structural basis of DOTMA for its high intravenous transfection activity in mouse , 2000, Gene Therapy.
[35] J. L. Nieva,et al. Induction of aggregation and fusion of cholesterol-containing membrane vesicles by an anti-cholesterol monoclonal antibody. , 2000, Journal of lipid research.
[36] T Salditt,et al. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.
[37] F. Szoka,et al. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. , 1998, Biochimica et biophysica acta.
[38] R. Kumar,et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. , 1994, The Journal of biological chemistry.
[39] K. Maruyama,et al. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). , 1992, Biochimica et biophysica acta.
[40] N. Dock. The ABC's of viral hepatitis , 1991 .
[41] M. van Galen,et al. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition. , 1986, Biochimica et biophysica acta.
[42] B. de Kruyff,et al. The function of sterols in membranes. , 1976, Biochimica et biophysica acta.
[43] George A. Calin,et al. RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.
[44] P. Ruck,et al. Bcl-2 gene silencing in pediatric epithelial liver tumors. , 2008, The Journal of surgical research.
[45] S. Krugman. The Gordon Wilson Lecture. The ABC's of viral hepatitis. , 1992, Transactions of the American Clinical and Climatological Association.
[46] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .